Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Clinical trial NCT04992988 · UNKNOWN

Trial details

NCT number: NCT04992988
Sponsor: Cancer Hospital of Guangxi Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Toripalimab Recurrent Nasopharyngeal Squamous Cell Carcinoma

Start date: 2020-06-28
Primary completion: 2022-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.